Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.8B | 12.0B | 11.9B | 11.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.5B | 1.5B | 1.5B | 1.5B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 99M | 98M | 98M | 98M |
| Other income expense | 112M | 112M | 120M | 105M |
| Pretax income | 468M | 2.6B | 1.6B | 656M |
| Tax provision | 73M | 512M | 300M | 122M |
| Net income | 395M | 2.1B | 1.3B | 534M |
| Basic EPS | 1.7 | 9.1 | 5.5 | 2.3 |
| Diluted EPS | 1.7 | 9.0 | 5.4 | 2.3 |
| Basic average shares | 226.9M | 226.9M | 227.4M | 228.6M |
| Diluted average shares | 230.4M | 230.7M | 230.6M | 231.5M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 395M | 2.1B | 1.3B | 534M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 3M | 16M | 10M | 5M |